PLGA nanoparticles of anti tubercular drug: Drug loading and release studies of a water in-soluble drug

International Journal of PharmTech Research

Volumn 2, Issue 3, 2010, Pages 2116-2123

  Tripathi, Akansha ^a   Gupta, Ranjana ^a   Saraf, Shubhini A ^a  

^a BABU BANARASI DAS NATIONAL INSTITUTE OF TECHNOLOGY AND MANAGEMENT   (India)

Author keywords

Antitubercular drugs (ATDs); Poly (D,L lactic co glycolide) (PLGA); Poly vinyl Alcohol (PVA); Rifampicin

Indexed keywords

NANOPARTICLE; POLY LACTIC CO GLYCOLIC ACID NANOPARTICLE; POLYMER; POLYVINYL ALCOHOL; RIFAMPICIN; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SOLUBILITY; EMULSION; EVAPORATION; PARTICLE SIZE; SLOW DRUG RELEASE; ULTRASOUND;

EID: 77957555841     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Davis S.S. and Illum L., Int, J. Pharm., 1998, 176, 1-8.
2. Bala I., Hariharan S. and Kumar R., Crit. Rev. Ther. Drug. Carrier System, 2004, 21, 5, 387-422.
3. Anderson J.M. and Shive M.S., Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug. Delivery Rev., 1997, 28, 5-24.
4. Dutt M., Khuller G.K., Chemothearpy of Mycobacterium tuberculosis infection in mice with a combination of isoniazid entrapped in poly (DLlactide- co-glycolide) microparticle. J. Antimicrob. Chemother., 2001, 4, 829-835.
5. Dutt M., Khuller G.K., Therapeutics efficacy of poly (DL-lactide-co-glycolide)-encapsulated antitubercular druds against Mycobacterium tuberculosis infection induced in mice, Antimicrob. agent and Chemother., 2001, 45, 363-366.
6. Ain Q., Sharma S., Khuller G.K., Role of poly (DL-lactide-co-glycolide) in development of a sustained oral drug delivery system for antitubercular drugs(s), Int. J. Pharm., 2002, 239, 37-46.
7. Ain Q., Sharma S., Khuller G.K., Chemotherapeutic potential of orally administered microparticles containing isoniazid, rifampicin and pyrazinamide against experimental tuberculosis, Antimicrob. Agents Chemother., 2003, 47, 3005-7.
8. Pandey R., Zahoor A., Sharma S., Khuller G.K., Nanoparticle- encapsulated antitubercular drugs as a potential oral drug delivery system against experimental murine tuberculosis, Tuberculosis (Ed-inb), 2003, 83, 373-8.
9. Vandervoort J. and Ludwig A., Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study, Int. J. Pharm., 2002, 238, 79-92.
10. Agnihotri S.M. and Vavia P.R. Diclofenac-loaded biopolymeric nanosuspension for ophthalmic application, Nanomedicine: NBM, 2009, 5, 90-95.
11. Gupta H., Aqil M., Khar R.K., Ali A., Bhatnagar A., Mittal G., Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery, Nanomedicine: NBM, 2010, 6, 324-333.
12. Pandey R., Zahoor A., Sharma S., Khuller G.K., Tuberculosis, 2003, 83, 373-378.
13. Pillay V., Toit L.S., Danckwerts M.P., Tuberculosis chemotherapy: current drug delivery approaches, Respiratory Research, 2006, 7, 1-18.
14. Govender J., Stolnik S., Garnett M.C., Illum L., Davis S.S., J. Control Rel., 1999, 57, 171-185.